Cancer Immunotherapy

Cancer Immunotherapy

Teplow, David B.

126,88 €(IVA inc.)

Cancer Immunotherapy, Volume 209 covers the progress that has been made in cancer immunotherapy. This volume surveys exciting developments in the field while also highlighting its promise and problems. Chapters in this release include The Promise, Progress, and Challenges of In Situ Immunization Agents in Cancer Immunotherapy, Breakthroughs in Synthetic Controlling Strategies for Precision in CAR-T Therapy, Non-coding RNAs in cancer immunotherapy: a solution to overcome immune resistance?, Rational Design of adjuvants boosts cancer vaccines, Emerging Drug delivery systems to alter Tumor immunosuppressive microenvironment: overcoming the challenges in immunotherapy for Glioblastoma.Other chapters cover Magnetic Nanoparticles: An Emerging Nanomedicine for Cancer Immunotherapy and Clinical and basic science aspects of innate lymphoid cells as novel immunotherapeutic targets in cancer treatment. Discusses immune surveillance of tumors and how it is compromisedPresents new approaches to the development and delivery of cancer vaccines and cytotoxic T-cells to the tumor siteDemonstrates how new molecular biological approaches may augment the efficacy of CAR-T cells and dampen the effects of non-coding RNAs INDICE: 1. The Promise, Progress, and Challenges of In Situ Immunization Agents in Cancer ImmunotherapyMatt Giacalone2. TBATiziana Vavalà3. Breakthroughs in Synthetic Controlling Strategies for Precision in CAR-T TherapyRio Sugimura and Logan Tang4. Non-coding RNAs in cancer immunotherapy: a solution to overcome immune resistance?Moein Ala, Fatemeh Afra, Seyed Parsa Eftekhar and Amir Salehi Farid5. Rational Design of adjuvants boosts cancer vaccinesXia Li, Mitsuhiro Ebara, Naoto Shirahata, Tomohiko Yamazaki and Nobutaka Hanagata6. Emerging Drug delivery systems to alter Tumor immunosuppressive microenvironment: overcoming the challenges in immunotherapy for GlioblastomaKhushwant S. Yadav7. MAGNETIC NANOPARTICLES: AN EMERGING NANOMEDICINE FOR CANCER IMMUNOTHERAPYPhoomipat Jungcharoen, Jutatip Panaampon, Thanit Imemkamon and Charupong Saengboonmee8. TBAMi Liu9. TBASarbajit Mukherjee10. TBAGerardo Cazzato III11. Clinical and basic science aspects of innate lymphoid cells as novel immunotherapeutic targets in cancer treatmentEric Jou

  • ISBN: 978-0-443-23534-4
  • Editorial: Academic Press
  • Encuadernacion: Cartoné
  • Páginas: 300
  • Fecha Publicación: 01/11/2024
  • Nº Volúmenes: 1
  • Idioma: Inglés